| Cost of Revenue | 0.14 | - | - | - | - | |
| Gross Profit | -0.14 | - | - | - | - | |
| Selling, General & Admin | 9.41 | 9.03 | 14.45 | 15.93 | 10.06 | |
| Research & Development | 6.08 | 3.86 | 6.91 | 6.33 | 7.83 | |
| Operating Expenses | 16.14 | 19.23 | 27.43 | 33.74 | 29.84 | |
| Operating Income | -16.28 | -19.23 | -27.43 | -33.74 | -29.84 | |
| Interest Expense | -0.03 | -0 | -0.05 | -0.07 | -0.24 | |
| Interest & Investment Income | 0.57 | 0.79 | 0.37 | 0 | 0 | |
| Other Non Operating Income (Expenses) | 0.09 | 0.21 | 0.52 | 0.68 | 2.56 | |
| EBT Excluding Unusual Items | -15.64 | -18.24 | -26.59 | -33.13 | -27.51 | |
| Gain (Loss) on Sale of Investments | -0 | -0.38 | -0.23 | -0.86 | -0.77 | |
| Asset Writedown | - | -4.56 | - | - | -0.09 | |
| Legal Settlements | - | - | - | - | -0.76 | |
| Other Unusual Items | 0.73 | 4.94 | 0.12 | 0.05 | 0.68 | |
| Pretax Income | -14.92 | -18.23 | -26.7 | -33.94 | -28.45 | |
| Earnings From Continuing Operations | -14.92 | -18.23 | -26.7 | -33.94 | -28.45 | |
| Earnings From Discontinued Operations | - | - | 3.1 | -1.35 | -3.35 | |
| Net Income to Company | -14.92 | -18.23 | -23.61 | -35.29 | -31.8 | |
| Minority Interest in Earnings | 0.71 | 0.33 | - | - | - | |
| Net Income | -14.2 | -17.9 | -23.61 | -35.29 | -31.8 | |
| Net Income to Common | -14.2 | -17.9 | -23.61 | -35.29 | -31.8 | |
| Shares Outstanding (Basic) | 1 | 1 | 1 | 1 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 1 | 1 | 0 | |
| Shares Change (YoY) | 86.67% | 2.21% | 10.84% | 190.15% | 70.69% | |
| EPS (Basic) | -12.49 | -29.39 | -39.62 | -65.63 | -171.62 | |
| EPS (Diluted) | -12.49 | -29.39 | -39.62 | -65.63 | -171.62 | |
| Free Cash Flow | -7.88 | -10.83 | -28.45 | -20.75 | -19.13 | |
| Free Cash Flow Per Share | -6.93 | -17.78 | -47.74 | -38.59 | -103.25 | |
| EBITDA | -15.79 | -16.73 | -22.9 | -29.7 | -25.94 | |
| D&A For EBITDA | 0.49 | 2.51 | 4.53 | 4.05 | 3.9 | |
| EBIT | -16.28 | -19.23 | -27.43 | -33.74 | -29.84 | |